MEDX vs. BENJ
MEDX (Horizon Kinetics Medical ETF) and BENJ (Horizon Landmark ETF) are both exchange-traded funds - MEDX is a Health & Biotech Equities fund actively managed by Horizon, while BENJ is a Ultrashort Bond fund actively managed by Horizon. Both are actively managed. Over the past year, MEDX returned 32.14% vs 3.78% for BENJ. At a correlation of -0.04, they often move in opposite directions. MEDX charges 0.85%/yr vs 0.40%/yr for BENJ.
Performance
MEDX vs. BENJ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MEDX achieves a 3.90% return, which is significantly higher than BENJ's 1.46% return.
MEDX
- 1D
- 3.04%
- 1M
- 5.53%
- YTD
- 3.90%
- 6M
- 3.58%
- 1Y
- 32.14%
- 3Y*
- 6.55%
- 5Y*
- —
- 10Y*
- —
BENJ
- 1D
- -0.01%
- 1M
- 0.29%
- YTD
- 1.46%
- 6M
- 1.80%
- 1Y
- 3.78%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
MEDX vs. BENJ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
MEDX Horizon Kinetics Medical ETF | 3.90% | 25.90% |
BENJ Horizon Landmark ETF | 1.46% | 3.75% |
Correlation
The correlation between MEDX and BENJ is -0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.05 |
Correlation (All Time) Calculated using the full available price history since Jan 24, 2025 | -0.04 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MEDX vs. BENJ — Risk / Return Rank
MEDX
BENJ
MEDX vs. BENJ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Horizon Kinetics Medical ETF (MEDX) and Horizon Landmark ETF (BENJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MEDX | BENJ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.87 | ||
| Sortino ratioReturn per unit of downside risk | -6.38 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 4.95 | -3.64 |
| Calmar ratioReturn relative to maximum drawdown | 3.06 | 9.71 | -6.65 |
| Martin ratioReturn relative to average drawdown | 8.51 | 45.83 | -37.31 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| MEDX | BENJ | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.78 | 5.65 | -3.87 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.32 | 6.41 | -6.09 |
Drawdowns
MEDX vs. BENJ - Drawdown Comparison
The maximum MEDX drawdown since its inception was -23.10%, which is greater than BENJ's maximum drawdown of -0.39%. Use the drawdown chart below to compare losses from any high point for MEDX and BENJ.
Loading charts...
Drawdown Indicators
| MEDX | BENJ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -23.10% | -0.39% | -22.71% |
Max Drawdown (1Y)Largest decline over 1 year | -10.54% | -0.39% | -10.15% |
Max Drawdown (3Y)Largest decline over 3 years | -23.10% | — | — |
Current DrawdownCurrent decline from peak | -2.68% | -0.01% | -2.67% |
Average DrawdownAverage peak-to-trough decline | -6.72% | -0.02% | -6.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.79% | 0.08% | +3.71% |
Volatility
MEDX vs. BENJ - Volatility Comparison
Horizon Kinetics Medical ETF (MEDX) has a higher volatility of 5.68% compared to Horizon Landmark ETF (BENJ) at 0.07%. This indicates that MEDX's price experiences larger fluctuations and is considered to be riskier than BENJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MEDX | BENJ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.68% | 0.07% | +5.61% |
Volatility (6M)Calculated over the trailing 6-month period | 13.41% | 0.23% | +13.18% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.12% | 0.67% | +17.45% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.04% | 0.60% | +16.44% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.04% | 0.60% | +16.44% |
MEDX vs. BENJ - Expense Ratio Comparison
MEDX has a 0.85% expense ratio, which is higher than BENJ's 0.40% expense ratio.
Dividends
MEDX vs. BENJ - Dividend Comparison
MEDX's dividend yield for the trailing twelve months is around 1.19%, while BENJ has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
BENJ Horizon Landmark ETF | 0.00% | 0.00% | 0.00% | 0.00% |
MEDX Horizon Kinetics Medical ETF | 1.19% | 1.23% | 1.92% | 4.94% |
Frequently Asked Questions
MEDX and BENJ have a correlation of -0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MEDX has higher volatility (5.68%) compared to BENJ (0.07%). In terms of maximum drawdown, MEDX dropped -23.10% vs BENJ's -0.39%.
On 1-year performance, MEDX leads with 32.14% vs 3.78% for BENJ. On fees, BENJ is cheaper at 0.40% per year. On volatility, BENJ has been the lower-risk option at 0.07%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, MEDX has performed better with a 32.14% return vs 3.78%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
BENJ is cheaper with a 0.40% expense ratio, compared with 0.85% for MEDX.
MEDX has the higher dividend yield at 1.19%, compared with 0.00% for BENJ.
MEDX is categorized as Health & Biotech Equities, while BENJ is Ultrashort Bond. Their fees differ too: 0.85% for MEDX and 0.40% for BENJ.
BENJ currently has the higher Sharpe Ratio (5.65 vs 1.78), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MEDX and BENJ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer